Ann: Positive IHL-675A in vivo results and FDA Pathway, page-100

There's that, and then there's the converse angle: Camargo knows a hot proposition when it sees one?
As others have commented, their 98% FDA success rate means they know how to pick'em.

So we can congratulate the board for knowing to jump in with Camargo, but it is quite possible Camargo hunted IHL down themselves. Covid19 needs all the anti-inflammatory fire power we can muster, and the current situation can launch a small handful of new drugs into the stratosphere.